Ivan Hyep, Chief Financial Officer at Bicara Therapeutics Inc. (BCAX), sold 28,000 shares at $28.60 ($808K) on 2026-07-08, disclosed to the SEC on 2026-07-10.
Scheduled sale ($808k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.60 | 22,757 | $651K | 80.6% |
| 2 | $29.82 | 4,413 | $132K | 16.3% |
| 3 | $30.31 | 830 | $25K | 3.1% |
| Total | $28.85 avg | 28,000 | $808K | 100% |
| Filing → |
| BCAX | SELL | 2026-04-22 | $212K | — | Filing → |
| BCAX | SELL | 2026-03-24 | $341K | — | Filing → |
| BCAX | SELL | 2026-03-05 | $602K | — | Filing → |